BellRing Brands, Inc. (BRBR): what the price requires
The current priced-in claim for BellRing Brands, Inc. (BRBR) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/BRBR
Headline
| Field | Value |
|---|---|
| Ticker | BRBR |
| Company | BellRing Brands, Inc. |
| Current price | $12.60/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 4.1% |
| Operating margin today | 12.5% |
| Margin compression implied | -8.4pp |
| Multiple paid | 9x operating income |
The operating-margin requirement is derived from the framework's value band at year 7, a separately labeled basis from the headline growth/duration solve.
The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.
Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -1.45σ |
| cohort percentile (of 69 peers) | 7 |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple; earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | — | 0 | — |
| Earnings | 2.35x | 3 | expensive |
| Relative | 0.50x | 2 | justifies |
| Growth | — | 0 | — |
Families that justify the price: Relative Families that call it expensive: Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.8%); the inversion above states its own rate.
Per-Model Detail (n=5)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $54.47 | 0.23x | no | FCF base $0.2B, growth 6% (input: historical growth), terminal g 4.0%, WACC 6.8%, 6yr projection |
| DCF Exit Multiple | Growth | $19.24 | 0.65x | no | Exit EV/EBITDA: 6.9x / 8.9x / 10.9x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $24.87 | 0.51x | yes | P/E 16.94x (blended: static sector reference 22x + trailing (TTM) 9x), scenarios: 14.1x / 16.9x / 19.7x (bear / base = reference held flat / bull), EV/EBITDA 14x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | — | — | no | — |
| Two-Stage Excess Return | Asset | — | — | no | — |
| Discounted Future Market Cap | Growth | $10.02 | 1.26x | no | Rev $2.3B, growth 6% (input: historical growth; tapered), Terminal P/S: 0.5x / 0.6x / 0.7x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $17.90 | 0.70x | no | Normalized EBIT (5y avg op income, one-time charges added back) $0.30B × (1−26%) / WACC 6.8% → EPV (no growth) |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | $25.51 | 0.49x | yes | EBITDA $0.30B × sector EV/EBITDA 14.0x |
| FCF Yield | Earnings | $7.33 | 1.72x | yes | FCF $186.3M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $5.35 | 2.35x | yes | SBC-adj FCF $0.16B (FCF $0.19B − SBC $0.02B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $1.08 | 11.66x | yes | EPS $1.29 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $39.69 | 0.32x | no | Revenue $2.33B × sector P/S 2.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $13.95 | 0.90x | no | EPS $1.29 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $1.2b |
| Net debt / NOPAT (after-tax) | 5.51x |
| Net debt / operating income (pre-tax) | 4.07x |
| Share count CAGR (dilution) | 16.9% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
At about $9.45 the market pays roughly 8 times operating income, a multiple so low the price sits below what even a 5% per year operating-profit decline would warrant. The stock has fallen hard, and the price is bracing for shrinkage.
The models disagree sharply. The relative and sector frames land far above the price, Relative Valuation at $24 and EV/EBITDA Relative at $26, while the conservative cash-flow frames sit near the price. The earnings-power model says expensive, the multiple frames say cheap.
The reason for the divergence is a sudden profit collapse. The most recent quarter showed adjusted EBITDA falling to $53.8 million from $118.6 million on cost inflation and competition, and management cut full-year guidance. The conservative read is the honest one until the margin stabilizes.
Bull Case
What the standard valuation models miss about BellRing is the franchise strength buried under a single bad quarter. The headline numbers look ugly because earnings fell, but the business is the leader in ready-to-drink protein shakes through Premier Protein, in a category management describes as still growing 8%. A category leader in a structurally healthy market is a different asset than the price, around 8 times operating income, implies. At that multiple the market is pricing terminal decline, and the relative-valuation frames push back hard: Relative Valuation lands at $24, EV/EBITDA Relative at $26, and a sector price-to-sales fallback at $40, all multiples of the price.
The demand backdrop is the part the depressed earnings obscure. Net sales still grew in the most recent quarter, with Premier Protein sales up modestly on distribution gains and promotional activity, and the overall ready-to-drink shake category growing 8%. Protein and functional nutrition are a durable consumer trend, not a fad, and BellRing has the brand and shelf presence to participate. Revenue of roughly $2.3 billion against a market value near $1.1 billion means the stock trades at about half a year of sales, an unusually low multiple for a branded consumer-staples leader.
The cash generation supports the floor. The company generates meaningful free cash flow, and the Earnings Power Value model, built on normalized five-year operating income, lands at $20, more than double the price. The DCF Exit Multiple lands at $17. These frames say that even on conservative, no-growth assumptions the normalized earnings power is worth well above where the stock trades. If the margin pressure from cost inflation and freight proves cyclical rather than permanent, and the category keeps growing, a branded leader priced for decline has substantial room to re-rate toward the cluster of valuation methods that sit far above the price.
Bear Case
Frame the bear case around the model disagreement, because the conservative methods are telling the more honest story. The relative and sector frames land far above the price, but they capitalize a level of earnings the company just demonstrated it may not sustain. The methods worth weighting are the ones anchored to recent reality, and they cluster near the price: the SBC-adjusted FCF Yield at $5.35, the plain FCF Yield at $7.33, and the Discounted Future Market Cap at $7.52, all at or below the current level. When the cash-flow frames sit at the price while the multiple frames sit far above it, the gap is not hidden value, it is the market pricing in the risk that the optimistic frames are wrong.
The reason to trust the conservative read is the recent collapse in profitability. In the most recent quarter, adjusted EBITDA fell to $53.8 million from $118.6 million a year earlier, operating profit dropped, and net earnings fell, driven by cost inflation, unfavorable price and mix, and higher freight costs. Management cut full-year guidance to net sales growth of 0% to 2% and adjusted EBITDA of $315 to $335 million, implying a margin of about 14%, well below prior levels. A staples company that loses half its quarterly EBITDA and cuts guidance is not experiencing noise; it is showing that its pricing power and cost structure are under real strain.
The competitive threat is the structural worry behind the numbers. Management acknowledged the ready-to-drink shake category, while healthy, has drawn roughly 40 new entrants, which has raised the cost of defending market leadership. More competitors means more promotional spending, more shelf-space battles, and compressed margins, exactly the dynamics that hit this quarter. The inversion reads as below-floor, with the fair value floored right at the price, and the characterization is that only the relative multiple justifies the price while earnings-power says expensive. The bull case requires the margin to recover and the competition to rationalize. The bear case is that a profit collapse, a guidance cut, and a flood of new competitors are the conservative frames being proven right, and that the cheap multiple is cheap for a reason.
Valuation
BellRing is priced as a whole company on its operating earnings, and the read is stark: at about $9.45 (June 27, 2026) the market pays roughly 8 times company-wide operating income, low enough that the inversion describes the price as sitting below what even a 5% per year operating-profit decline would warrant. That is a bound, not a solved growth rate. The price is underwriting decline, and the fair-value range is floored right at the price, a below-floor signal.
The model spread is the whole story here, and it splits cleanly. The optimistic frames sit far above the price: Relative Valuation at $24, EV/EBITDA Relative at $26, P/Sales Sector at $40, and Earnings Power Value at $20, all crediting either a sector multiple or normalized earnings. The conservative, cash-flow-anchored frames sit at or below the price: SBC-adjusted FCF Yield at $5.35, FCF Yield at $7.33, and Discounted Future Market Cap at $7.52. The Ben Graham Formula lands at just $1.08 because trailing EPS growth is negative. The characterization is that relative-multiple justifies the price while earnings-power says expensive, which is unusual and reflects the recent earnings disruption.
The interpretation hinges on whether you believe the recent profit collapse is cyclical or structural. If the margin recovers to historical levels, the relative and earnings-power frames near $20 to $26 are the right anchors, and the stock is deeply cheap. If the reduced guidance, with adjusted EBITDA cut to $315 to $335 million and a roughly 14% margin, is the new normal, then the conservative cash-flow frames near $5 to $7 are honest, and the stock is fairly valued to expensive. The priced-in label is within range with limited comparison data, so treat it directionally. The deciding variables are margin recovery against cost inflation and freight, the intensity of competition in the ready-to-drink shake category, and whether Premier Protein's volume and pricing hold as roughly 40 new entrants compete for shelf space.
Catalysts
Second-quarter fiscal 2026 results, reported in May, were the recent driver and they were weak. Net sales rose about 2% to $598.7 million on volume growth, but operating profit fell to $66.0 million, net earnings to $33.9 million, and adjusted EBITDA dropped sharply to $53.8 million from $118.6 million a year earlier, driven by cost inflation, unfavorable price and mix, and higher freight costs. Premier Protein sales rose 1.7% on promotional activity and distribution gains, while Dymatize sales fell 1.9%.
The guidance cut was the key signal. Management now expects fiscal 2026 net sales of $2.325 to $2.365 billion, growth of 0% to 2%, and adjusted EBITDA of $315 to $335 million, implying a margin of about 14%, below prior expectations. Management noted the ready-to-drink shake category remains healthy with 8% growth but that roughly 40 new entrants have raised the cost of defending market leadership.
The watch items are the recovery path for margins against cost and freight inflation, competitive intensity in the ready-to-drink shake category and its effect on promotional spending, Premier Protein volume and distribution trends, and progress against the reduced full-year guidance. The next quarterly print is the key near-term marker for whether the margin stabilizes or erodes further. Sources: BellRing Brands Q2 fiscal 2026 results and 8-K (stocktitan.net), earnings call and guidance coverage (finance.yahoo.com, fool.com); current price and category context (stockanalysis.com, marketbeat.com).
Peer Cohorts (Per Segment, With Filing Citations)
BellRing Brands (single segment) (reported)
- POST (Post Holdings, Inc.)
- (no filing in the citation store)
- SJM (THE J. M. SMUCKER COMPANY)
- (no filing in the citation store)
- HRL (HORMEL FOODS CORPORATION)
- (no filing in the citation store)
- CAG (CONAGRA BRANDS, INC.)
- (no filing in the citation store)
- MZTI (The Marzetti Company)
- (no filing in the citation store)
- LW (Lamb Weston Holdings, Inc.)
- (no filing in the citation store)
- MKC (McCORMICK & COMPANY, INCORPORATED)
- (no filing in the citation store)
- FLO (FLOWERS FOODS, INC)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.